endocrinology

EMA starts review of Xtandi in hormone-sensitive prostate cancer

https://pharmaphorum.com/news/ema-starts-review-of-xtandi-in-hormone-sensitive-prostate-cancer/

Samsung Bioepis signs R&D agreement with Takeda

https://pharmaphorum.com/news/samsung-bioepis-signs-rd-agreement-takeda/

Growth hormone could be filed without further trials, says OPKO

https://pharmaphorum.com/news/opko-growth-hormone-filed-without-trials/

OPKO weekly growth hormone jab fails in phase 3

https://pharmaphorum.com/news/opko-weekly-growth-hormone-jab-fails-in-phase-3/

Close in 10 seconds

Pharmaphorum.com

Search